Rat liver lysosomal and mitochondrial activities are modified by anabolic-androgenic steroids

Medicine and Science in Sports and Exercise

Volumn 31, Issue 2, 1999, Pages 243-250

  Molano, Fulgencio ^a   Saborido, Ana ^a   Delgado, Jerónimo ^a   Morán, María ^a   Megías, Alicia ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Exercise training; Fluoxymesterone; Hepatotoxicity; Male rats; Methylandrostanolone; Stanozolol

Indexed keywords

ANDROGEN; ANDROSTANOLONE DERIVATIVE; FLUOXYMESTERONE; STANOZOLOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; LIVER LYSOSOME; LIVER MITOCHONDRION; LIVER TOXICITY; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; RAT; STEROID THERAPY; TREADMILL EXERCISE;

EID: 0033014816     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005768-199902000-00007     Document Type: Article

References (40)

1. ALEN, M. Androgenic steroid effects on liver and red cells. Br. J. Sports Med. 19:15-20, 1985.
2. AMERICAN COLLEGE OF SPORTS MEDICINE. Position stand on the use of anabolic-androgenic steroids in sports. Med. Sci. Sports Exerc. 19:534-539, 1987.
3. BAUMAN, D. H., J. T. RICHERSON, and A. L. BRITT. A comparison of body and organ weights, physiological parameters, and pathologic changes in target organs of rats given combinations of exercise, anabolic hormone, and protein supplementation. Am. J. Sports Med 16:397-402, 1988.
4. BRONSON, F. H., and C. M. MATHERNE. Exposure to anabolicandrogenic steroids shortens life span of male mice. Med. Sci. Sports Exerc. 29:615-619, 1997.
5. CABASSO, A. Peliosis hepatis in a young adult bodybuilder. Med. Sci. Sports Exerc. 26:2-4, 1994.
6. COOPERSTEIN, S. J., A. LAZAROW, and N. J. KURFESS. A microspectrophotometric method for the determination of succinic dehydrogenase. J. Biol. Chem. 186:129-139, 1950.
7. CORNWALL, G. A., M.-C. ORGEBIN-CRIST, and S. R. HANN. Differential expression of the mouse mitochondrial genes and the mitochondrial RNA-processing endoribonuclease RNA by androgens. Mol. Endocrinol. 6:1032-1042, 1992.
8. DEMONACOS, C. V., N. KARAYANNI, E. HATZOGLUO, C. TSIRIYIOTIS, D. A. SPANDIDOS, and E. SEREKIS. Mitochondrial genes as sites of primary action of steroid hormones. Steroids 61:226-232, 1996.
9. DUFOUR, J.-F., A. ZIMMERMANN, and J. REICHEN. Increased hepatic lysosomal activity in biliary cirrhosis originates from hepatocytes rather than from macrophages. J. Hepatol. 20:524-530, 1994.
10. FORBES, G. M., B. A. BRAMSTON, and B. J. COLLINS. Anabolic steroid hepatotoxicity: lessons to be learnt? Aust. N. Z. J. Med. 23:309-310, 1993.
11. GRAGERA, R., A. SABORIDO, F. MOLANO, L. JIMENEZ, E. MUÑIZ, and A. MEGIAS. Ultrastructural changes induced by anabolic steroids in liver of trained rats. Histol. Histopath. 8:449-455, 1993.
12. GUZMAN, M., A. SABORIDO, J. CASTRO, F. MOLANO, and A. MEGIAS, Treatment with anabolic steroids increases the activity of the mitochondrial outer carnitine palmitoyltransferase in rat liver and fast-twitch muscle. Biochem. Pharmacol. 41:833-835, 1991.
13. HARPUR, R. P. The rat as a model for physical fitness studies. Comp. Biochem. Physiol. 66A:553-574, 1980.
14. HARTGENS, F., H. KUIPERS, J. A. WIJNEN, and H. A. KEIZER. Body composition, cardiovascular risk factors and liver function in long-term androgenic-anabolic steroids using bodybuilders three months after drug withdrawals. Int. J. Sports Med. 17:429-433, 1996.
15. HICKSON, R. C., K. L. BALL and M. T. FALDUTO. Adverse effects of anabolic steroids. Med. Toxicol. Adverse Drug Exp. 4:254-271, 1989.
16. ISHAK, K. G., and H. J. ZIMMERMAN. Hepatotoxic effects of the anabolic/androgenic steroids. Semin. Liver Dis. 7:230-236, 1987.
17. KOENIG, H., A. GOLDSTONE, and C. Y. LU. Testosterone-mediated sexual dimorphism of the rodent heart: Ventricular lysosomes. mitochondria, and cell growth are modulated by androgens. Circ. Res. 50:782-787, 1982.
18. KUIPERS, H., J. A. G. WIJNEN, F. HARTGENS, and S. M. M. WILLEMS. Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders. Int. J. Sports Med. 12:413-418, 1991.
19. LAWLER, J. M., S. K. POWERS, J. HÄMMEREN, and A. D. MARTIN. Oxygen cost of treadmill running in 24-month-old Fischer-344 rats. Med. Sci. Sports Exerc. 25:1259-1264, 1993.
20. LOWRY, O. H., N. J. ROSEBROUGH, A. L. FARR, and R. J. RANDALL. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275, 1951.
21. LUKAS, S. E. Current perspectives on anabolic-androgenic steroid abuse. Trends Pharmacol. Sci. 14:61-68, 1993.
22. MOHAN, P. F., and M. P. CLEARY. Short-term effects of dehydroepiandrosterone treatment in rats on mitochondrial respiration. J. Nutr. 121:240-250, 1991.
23. MOORADIAN, A. D., J. E. MORLEY, and S. G. KORENMAN. Biological actions of androgens. Endocr. Rev. 8:1-28, 1987.
24. MORGAN, D. M. L., J. D. PEARSON, and J. L. GORDON. Lysosomal hydrolases of human vascular cells: response to agonists of endothelial function. Biochim. Biophys. Acta 1010:184-190, 1989.
25. NAKANO, A., D. L. MARKS, P. S. TIETZ, P. C. DE GROEN and N. F. LARUSSO. Quantitative importance of biliary excretion to the turnover of hepatic lysosomal enzymes. Hepatology 22:262-266, 1995.
26. NISHINO, Y. Effects of androgens and related steroids on liver functions and enzymes. Pharmacol. Ther. B1:189-207, 1975.
27. SAARTOK, T., E. DAHLBERG, and J.-A. GUSTAFSSON. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin. Endocrinology 114: 2100-2106, 1984.
28. SABORIDO, A., J. VILA, F. MOLANO, and A. MEGIAS. Effect of anabolic steroids on mitochondria and sarcotubular system of skeletal muscle. J. Appl. Physiol. 70:1038-1043, 1991.
29. SABORIDO, A., F. MOLANO, and A. MEGIAS. Effect of training and anabolic-androgenic steroids on drug metabolism in rat liver. Med. Sci. Sports Exerc. 25:815-822, 1993.
30. SEWELL, R. B., S. S. BARHAM, and N. F. LARUSSO. Effect of chloroquine on the form and function of hepatocyte lysosomes. Morphological modification and physiologic alterations related to the biliary excretion of lipids and proteins. Gastroenterology 85: 1146-1153, 1983.
31. SHERRATT, H. S. A., N. J. WATMOUGH, M. A. JOHNSON, and D. M. TURNBULL. Methods for study of normal and abnormal skeletal muscle mitochondria. Methods Biochem. Anal. 33:243-335, 1988.
32. SØE, K. L., M. SØE, and C. GLUUD. Liver pathology associated with the use of anabolic-androgenic steroids. Liver 12:73-79, 1992.
33. SOMANI, S. M., S. K. GUPTA, S. FRANK, and C. N. CORDER. Effect of exercise on disposition and pharmacokinetics of drugs. Drug Dev. Res. 20:251-275, 1990.
34. SRERE, P. A. Citrate synthase. Methods Enzymol. 13:3-5, 1969.
35. SWIERCZYNSKI, J., and D. MAYER. Dehydroepiandrosterone-induced lipid peroxidation in rat liver mitochondria. J. Steroid Biochem. Mol. Biol. 58:599-603, 1996.
36. TAKALA, T. E. S., K. KIVILUOMA, M. KIHLSTRÖM, P. RÄMÖ, and V. VIHKO. Effects of physical training, methandione and their combination on the lysosomal hydrolytic activities in dog heart. Int. J. Sports Med. 13:52-55, 1992.
37. WATKINS, J. B. III, S. T. CRAWFORD, and R. A. SANDERS. Chronic voluntary exercise may alter hepatobiliary clearance of endogenous and exogenous chemicals in rats. Drug Metab. Dispos. 22: 537-543, 1994.
38. WELDER, A. A., J. W. ROBERTSON, and R. B. MELCHERT. Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures. J. Pharmacol. Toxicol. Methods 33:187-195, 1995.
39. WILSON, C. M., D. F. KIMBERLIN. J. E. GRIFFIN, and J. D. WILSON. Specificity of androgen resistance in Mus caroli kidney. Biochem. Genet. 26:705-716, 1988.
40. YESALIS, C. E., and M. S. BAHRKE. Anabolic-androgenic steroids: current issues. Sports Med. 19:326-340, 1995.